Navigation Links
Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
Date:2/6/2008

A HREF="mailto:ken.apicerno@thermofisher.com">ken.apicerno@thermofisher.com

Website: http://www.thermofisher.com

Consolidated Statement of Income (a)

Three Months Ended

December December

31, % of 31, % of

(In millions except per share 2007 Revenues 2006 Revenues

amounts)

Revenues $2,621.1 $1,668.9

Costs and Operating Expenses

(e)(i)(j):

Cost of revenues 1,550.8 59.2% 1,061.5 63.6%

Selling, general and

administrative expenses 558.0 21.3% 403.0 24.1%

Amortization of acquisition-

related intangible assets 148.2 5.6% 93.2 5.6%

Research and development expenses 61.4 2.3% 52.2 3.1%

Restructuring and other costs,

net (d) 17.7 0.7% 32.1 1.9%

2,336.1 89.1% 1,642.0 98.4%

Operating Income 285.0 10.9% 26.9 1.6%

Interest Income 13.4 6.7

Interest Expense (f) (36.9) (26.9)

Other Income (Expense), Net (g) (3.5) 0.5

Income from Continuing Operations

Before Income Taxes 258.0 7.2

Income Tax (Provision) Benefit (23.7) 17.7

Income from Continuing Operations 234.3 24.9

Income from Discontinued Operations

(net of income tax

provision of $0.2 in 2006) - 0.5

Gain (Loss) on Disposal of

Discontinued Operations (net of

income ta
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related biology technology :

1. Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
2. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
3. Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Thermo Fisher Scientific to Present at the 26th Annual JPMorgan Healthcare Conference
5. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
6. Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing
7. MIT: Thermoelectric materials are 1 key to energy savings
8. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
9. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
10. Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers
11. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Newswire/--BlueMarbleEnergyCorp.announcedtodaythat...PDA)wererecentlyawarded$2millionbyWashingtonState,...ate/publicpartnershiptoconstructthestate,sfirstspe..., "Thisinvestmentwillsignificantlyspeedthedevelo...olnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."We...
(Date:11/24/2009)...dpointhasbeenmetforpatientswithadvanced-stage,orre.../PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ:...icalcompanyfocusedonendocrinetherapyandoncology,to...thitstargetedcytotoxicpeptideconjugate,AEZS-108(fo...ometrialcancer.Inapersonalizedhealthcareapproach,t...
(Date:11/24/2009).../PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: ...,today,announcedthatithassubmittedaMAAtotheEuropea...enzymereplacementtherapyindevelopment,forthetreatm...pplicationforvelaglucerasealfathathasbeensubmitted...a. , Basedonaglobalsupplyshortageofthecurrent...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc....cHealth,sExecutiveChairman,willpresentatthe21stAnn...Tuesday,December1,2009at10:00a.m.ET. ,, Toacces...ation,visittheInvestorRelationssectionofGenomicHea...Pleaseconnecttothewebsiteatleast15minutespriortoth...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...PRNewswire-FirstCall/ - Victhom Human Bionics Inc....ing of its updated corporate Website at www.victh... highlights advances in the Company,s two operatin...mplantable neurostimulation device for gait disord...cturing computerized prostheses for above-knee amp...
..., Jan. 9 Schering-Plough Corporation (NYSE: SGP...tion by Thomas P. Koestler, Ph.D., executive vice ...Institute, at the 27th Annual J.P. Morgan Healthca... at approximately 3:30 p.m. (PST) (6:30 p.m. EST).... R&D pipeline and select projects in developme...
... TRIANGLE PARK, N.C. and SANTA CLARA, Calif., Jan....oday that GSK has resubmitted the New Drug Applica...n (FDA) requesting approval of Solzira (TM) (gaba...he treatment of moderate-to-severe primary Restles...d that the data in a single study be reformatted. ...
Other Biology Technology:Victhom Announces Launch of Enhanced Company Website 2GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome 2GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome 3
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlif...ort revealing that the last remaining population o...y due to the rising tide of poaching and habitat l... inform Russian officials of what needs to be done...iggest cat. , The report was releas...
(Date:11/24/2009)..., Md. (November 24, 2009) New research on bacteri...cosystems reveals predictable temporal patterns, s...ies as markers for monitoring climate change in th... the Proceedings of the National Academy of Scien...es in the six rivers shifted synchronously over ti...
(Date:11/23/2009)...n, D.C. The community-associated strain of the de...sistant to most common antibioticsposes a far grea...ing its way into hospitals, according to a study i...ses . , The new threat is easily picked up in f...nd has increased the overall burden of MRSA within...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2Reward Yourself by Taking Your Dog to Obedience Training 58083 1Reward Yourself by Taking Your Dog to Obedience Training 58083 2Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 1Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 2Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 1Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 2
...HOUSTON -- (Nov. 19, 2008) -- Rice University scie...e stubborn pollutant TCE have created a method tha...ace of a catalyst as individual chemical bonds are...of the bonds between the atoms of our molecules," ... these vibrations change frequency and intensity w...
...MADISON, WI, NOVEMBER 17, 2008 Global land use pat...demand creative urban stormwater management. Tradi... the flow of runoff to waterways, but generally do...d by extensive pavement and compacted urban soils ...portunities affects groundwater recharge and has n...
...BOZEMAN -- The U.S. Department of Energy on Monday...stration Partnership at Montana State University t...f carbon dioxide into the sandstone rock layer ben...third and final phase of federal funding for the B...mately $14 million of the federal money will stay ...
Other Biology News:Researchers shed new light on catalyzed reactions 2Researchers shed new light on catalyzed reactions 3Urban trees enhance water infiltration 2Montana State partnership receives $66.9M for carbon sequestration 2Montana State partnership receives $66.9M for carbon sequestration 3
Goat Anti-Human EML1 (K-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Aldolase A (N-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
BPAEC (B302-05) from European Collection of Cell Cultures (ECACC)
Goat Anti-Human RECK (F-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: